A Case Series of Choroidal and Orbital Neuroendocrine Tumors: Metastasis-Reference-Cited by-同舟云学术

A Case Series of Choroidal and Orbital Neuroendocrine Tumors: Metastasis

Published:2024-03-14 Issue:5 Volume:53 Page:e445-e449
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Zhuang Tony Zibo¹,Bergstrom Chris²,El-Rayes Bassel F.³,Shaib Walid L.⁴

Affiliation:

1. Department of Medicine, Emory University School of Medicine, Atlanta, GA

2. Retina Consultants of Carolina, P.A., Greenville, SC

3. Department of Hematology and Medical Oncology, O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Birmingham, AL

4. Hematology and Oncology, Northwest Georgia Oncology, Marietta, GA.

Abstract

Abstract Neuroendocrine tumors (NETs) are rare cancers with heterogeneous histologies, response to treatments, and prognoses. Majority of these cancers originate in the gastrointestinal tract and metastasize to the liver. We report the cases of 5 patients with low-grade NET disease with rare metastases to the choroids. Two of the patients were treated with peptide receptor radionuclide therapy (lutetium 177 [177Lu]). This is the first report confirming peptide radionuclide therapy safety in patients with low-grade NET with ocular metastases.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference20 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;JAMA Oncol,2017

2. Cancer statistics, 2022;CA Cancer J Clin,2022

3. Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a SEER analysis;J Cancer,2012

4. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification;Ann N Y Acad Sci,2004

5. Uveal metastasis from carcinoid tumor. Clinical observations in nine cases;Ophthalmology,1994